Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype...

Area of Science:

• Genetics
• Molecular Biology
• Skeletal Dysplasias

Background:

• Osteogenesis imperfecta (OI), brittle bone disease, is a genetic disorder causing bone fragility.
• Mutations in type I collagen genes (COL1A1, COL1A2) are common causes of OI.
• The genotype-phenotype correlation in OI, especially lethal forms, requires further elucidation.

Purpose of the Study:

• To investigate COL1A1 and COL1A2 mutations in lethal OI type II.
• To determine the frequency of mutations in type I collagen genes in OI type II.
• To explore the role of other genes in OI type II etiology.

Main Methods:

• Sequencing of coding and exon-flanking regions of COL1A1 and COL1A2 in 63 OI type II subjects.
• Identification and characterization of mutations and single nucleotide polymorphisms (SNPs).
• Analysis of CRTAP and LEPRE1 genes in samples lacking collagen mutations.

Main Results:

• Identified 61 distinct heterozygous type I collagen mutations, 43 previously unreported.
• Discovered 17 novel COL1A1 SNPs and 18 novel COL1A2 SNPs.
• Found inactivating mutations in CRTAP and LEPRE1 in ~5% of OI type II cases without collagen mutations.

Conclusions:

• Provides extensive genotype data for OI type II, aiding genotype-phenotype correlation.
• Highlights the significant contribution of type I collagen gene mutations to lethal OI.
• Suggests recessive mutations in CRTAP and LEPRE1 are a notable cause of OI type II.